Novo Nordisk, the Danish company behind two popular obesity medications, is reaping huge profits and is now responsible for most of Denmark’s economic growth.
Author: Eshe Nelson
Advertisements
{
"slotId": "6845006044",
"unitType": "responsive",
"resize": "auto"
}